Filing Details

Accession Number:
0001209191-18-005678
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-26 17:52:49
Reporting Period:
2018-01-24
Accepted Time:
2018-01-26 17:52:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346830 Cara Therapeutics Inc. CARA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1166287 T Derek Chalmers C/O Cara Therapeutics, Inc.
107 Elm Street, 9Th Floor
Stamford CT 06902
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-24 12,500 $15.00 1,073,792 No 4 S Direct
Common Stock Acquisiton 2018-01-25 3,000 $6.00 1,076,792 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2018-01-25 3,000 $0.00 3,000 $6.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
191,000 2026-03-30 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2017.
  2. The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 8, 2017, in each case subject to the Reporting Person's Continuous service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.